Analysis of dyslipidemia in patients on chronic hemodialysis in Catalonia

Atherosclerosis

Volumn 184, Issue 1, 2006, Pages 94-102

  Cofan, Federico ^a   Vela, Emili ^b   Clèries, Montse ^b   Rioja, Carlos Rotellar ^c   Amenós, Aleix Cases ^d   Rocafort, Joan Gabàs ^e   Pujol, Ma Montserrat Carrera ^f   Aguilar, Mercé Pons ^g   Rotellar, Jesús Angel Oliver ^h   Jover, Josep Aguilera ^g   Boix, Antònia Sans ^g   Guasch, Rosa Samon ⁱ   Ocaña, Joan Carles Martinez ^g   Amigó, Josep Soler ^j   Bars, Angels Betriu ^k   Fontseré, Nestor ^l   Torguet, Pere ^m   Compte, Ma Teresa ^g   Sanz, Ramon ⁿ   Andrés, Enric ^o   Puig, Francesc Barbosa ^p   Andug, Josep Mallafre ^q   Calderón, Josep Calpe ^r   Osuna, Rosa Garcia ^s   Pascual, Ramon ^m   more..

^a UNIVERSITY OF BARCELONA   (Spain)

^b C Agy Hlth Technol Assess Res   (Spain)

^c Universidade de Lleida   (Spain)

^d Hospital Clínic i Provincial   (Spain)

^e Centre Nefrològic de Mataró   (Spain)

^f Centre de Diàlisi Verdum Clínic

^g CETIRSA ^*  (Spain)

^h HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

ⁱ Hospital Societat Socors Mutus de Mollet   (Spain)

^j Centre Hospitalari de Manresa   (Spain)

^k Sistemas Renals SA

^l HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^m HOSPITAL JOSEP TRUETA   (Spain)

ⁿ HOSPITAL DE FIGUERES   (Spain)

^o FUNDACIÓ PUIGVERT   (Spain)

^p HOSPITAL DEL MAR   (Spain)

^q HOSPITAL DOS DE MAIG   (Spain)

^r Clínica Renal TEFNUT

^s Hospital de Palamós   (Spain)

more..

Author keywords

HDL cholesterol; Hypercholesterolemia lipoproteins; Hyperlipidemia; Hypertriglyceridemia; LDL cholesterol lipoproteins; Renal dialysis

Indexed keywords

ANTILIPEMIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHILD; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; HEMODIALYSIS; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; STROKE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DYSLIPIDEMIAS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; RENAL DIALYSIS; RISK FACTORS; SEX FACTORS; SPAIN;

EID: 28344444292     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.03.021     Document Type: Article

References (29)

1. S.S. Prichard Impact of dyslipidemia in end-stage renal disease J Am Soc Nephrol 14 Suppl 4 2003 S315 S320
2. T. Shoji, Y. Nishizawa, and T. Kawagishi Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysis Atherosclerosis 131 1997 229 236
3. C. Wanner, and T. Quaschning Dyslipidemia and renal disease: pathogenesis and clinical consequences Curr Opin Nephrol Hypertens 10 2001 195 201
4. M. Koch, B. Kutkuhn, and E. Trenkwalder Apolipoprotein B, fibrinogen, HDL cholesterol and apolipoprotein(a) phenotypes predict coronary artery disease in hemodialysis patients J Am Soc Nephrol 8 1997 1889 1898
5. D. O'Byrne, S. Devaraj, and K.N. Islam Low-density lipoprotein (LDL)-induced monocyte-endothelial cell adhesion, soluble cell adhesion molecules, and autoantibodies to oxidized-LDL in chronic renal failure patients on dialysis therapy Metabolism 50 2001 207 215
6. M. Tamashiro, K. Iseki, and O. Sunagawa Significant association between the progression of coronary artery calcification and dyslipidemia in patients on chronic hemodialysis Am J Kidney Dis 38 2001 64 69
7. J.A. Hanley, and B.J. McNeil The meaning and use of the area under a receiver operating characteristics (ROC) curve Radiology 153 1982 29 36
8. D.M. Lee, C. Knight-Gibson, and O. Samuelsson Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency Kidney Int 61 2002 209 218
9. I. Rajman, L. Harper, D. McPake, M.J. Kendall, and D.C. Wheeler Low-density lipoprotein subfraction profiles in chronic renal failure Nephrol Dial Transplant 13 1998 2281 2287
10. E.A. Iliescu, S.M. Marcovina, A.R. Morton, and M.L. Koschinsky Apolipoprotein(a) phenotype, albumin clearance and plasma levels of lipoprotein(a) in peritoneal dialysis Nephron 88 2001 168 169
11. E. Emanuele, L.S. Lusignani, and E. Peros Lipoprotein(a)-associated atherothrombotic risk in hemodialysis patients Am J Nephrol 24 2004 221 229
12. U.S. Renal Data System, USRDS 2001 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2001.
13. Y. Liu, J. Coresh, and J.A. Eustace Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition JAMA 291 2004 451 459
14. F.C. Trespalacios, A.J. Taylor, L.Y. Agodoa, and K.C. Abbott Incident acute coronary syndromes in chronic dialysis patients in the United States Kidney Int 62 2002 1799 1805
15. K. Oi, T. Hirano, S. Sakai, Y. Kawaguchi, and T. Hosoya Role of hepatic lipase in intermediate-density lipoprotein and small, dense low-density lipoprotein formation in hemodialysis patients Kidney Int 71 1999 S227 S228
16. F. Tornero, A. Garcia-Garzon, and B. Rincon Apolipoprotein C-II and C-III anomalies in normolipemic and hyperlipemic patients with chronic kidney failure Nefrologia 20 2000 47 53
17. A.J. Ingram, A. Parbtani, and D.N. Churchill Effects of two low-flux cellulose acetate dialysers on plasma lipids and lipoproteins - a cross-over trial Nephrol Dial Transplant 13 1998 1452 1457
18. T. Shoji, Y. Nishizawa, T. Kawagishi, M. Emoto, and H. Morii Secondary hyperparathyroidism, decreased hepatic triglyceride lipase, elevated intermediate density lipoprotein and atherosclerosis in hemodialysis patients Nephron 78 1998 121 122
19. P. Ottosson, P.O. Attman, and C. Knight Do high-flux dialysis membranes affect renal dyslipidemia? ASAIO J 47 2001 229 234
20. D. Saltissi, C. Morgan, and B. Knight Effect of lipid-lowering dietary recommendations on the nutritional intake and lipid profiles of chronic peritoneal dialysis and hemodialysis patients Am J Kidney Dis 37 2001 1209 1215
21. D. Saltissi, C. Morgan, R.J. Rigby, and J. Westhuyzen Safety and efficacy of simvastatin in hypercholesterolemic patients undergoing chronic renal dialysis Am J Kidney Dis 39 2002 283 290
22. G. Hufnagel, C. Michel, and F. Vrtovsnik Effects of atorvastatin on dyslipidaemia in uraemic patients on peritoneal dialysis Nephrol Dial Transplant 15 2000 684 688
23. B. Bayes, M.C. Pastor, J. Bonal, J. Junca, and R. Romero Homocysteine and lipid peroxidation in haemodialysis: role of folinic acid and vitamin E Nephrol Dial Transplant 16 2001 2172 2175
24. M. Ando, T. Sanaka, and H. Nihei Eicosapentanoic acid reduces plasma levels of remnant lipoproteins and prevents in vivo peroxidation of LDL in dialysis patients J Am Soc Nephrol 10 1999 2177 2184
25. S.L. Seliger, N.S. Weiss, and D.L. Gillen HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients Kidney Int 61 2002 297 304
26. R.A. Viola, K.C. Abbott, and P.G. Welch A multidisciplinary program for achieving lipid goals in chronic hemodialysis patients BMC Nephrol 3 2002 9
27. S.L. Seliger, and C.O. Stehman-Breen Are HMG-CoA reductase inhibitors underutilized in dialysis patients? Semin Dial 16 2003 179 185
28. B.C. Fellstrom, H. Holdaas, and A.G. Jardine Why do we need a statin trial in hemodialysis patients? Kidney Int Suppl 84 2003 S204 S206
29. C. Wanner, V. Krane, W. Marz Deutsche Diabetes-Dialyse-Studie (4D) Study Group Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): demographic and baseline characteristics Kidney Blood Press Res 27 2004 259 266